WHO ICTRP trial

A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of…

TCTR20191126002 · Thai Clinical Trials Registry (TCTR) · Not Recruiting

Key facts

Trial ID TCTR20191126002
Public title A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Rosuvastatin 20 mg Film-coated Tablet and Reference Product (CRESTOR 20 mg) in Healthy Thai Volunteers under Fasting Conditions
Scientific title A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Rosuvastatin 20 mg Film-coated Tablet and Reference Product (CRESTOR 20 mg) in Healthy Thai Volunteers under Fasting Conditions
Primary sponsor International Bio Service Co. Ltd.
Registry Thai Clinical Trials Registry (TCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 1
Countries Thailand
Conditions Bioequivalence Study, Healthy, Thai, Volunteers Rosuvastatin, Bioequivalence Study, Healthy, Thai, Volunteers ;Rosuvastatin, Bioequivalence Study, Healthy, Thai, Volunteers
Interventions Generic rosuvastatin 20 mg film-coated tablet, Each tablet contains 20 mg of rosuvastatin as rosuvastatin calcium.,Rosuvastatin 20 mg film-coated tablet, CRESTOR 20 mg, Reg. No. 1C 33/57 (N), manufactured by IPR Pharmaceuticals Inc…
Registration date Nov 26, 2019
Target size 36
Registry page thaiclinicaltrials.org

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations